Clinical Trials Logo

Clinical Trial Summary

The use of non-nutritive sweeteners (NNS) in replacement of nutritive sweeteners (NS) could be a potential weight loss strategy as it may reduce energy intake. One concern with the replacement of NS with NNS is the risk of caloric compensation after consumption of NNS. Most studies have examined the effect of NNS foods and beverages on energy intake in the short-term (one-day or less), with results suggesting lack of compensation in the very short-term (less than one day), and then compensation, or over compensation, when the NNS products are consumed on one day with measures of energy intake taken over 1 to 2 days (Anton et al., 2010; Lavin et al., 1997; Overduin et al., 2016; Appleton et al., 2007; Piernas et al., 2013). Given these mixed results, it is still not clear if NNS foods and beverages are a beneficial strategy for decreasing energy intake. However most studies have been in lab-based settings, in which participants are consuming provided food at specific times. No study has reported on the effect of NNS foods or beverages consumed over several days and energy intake on these days when participants are in free-living situations.

Therefore, the purpose of this investigation is to evaluate how NNS beverage consumption affects energy intake in free-living situations over a span of three days. Through a 3x4 mixed design, participants will be randomized into one of three groups: NNS beverage, NS beverage, or carbonated water (control). Participants will be encouraged to go about their normal daily activities and not change any other aspect except for drink consumption. One baseline and three, 24-hour dietary recalls will be collected over the course of the study to analyze energy intake. The specific aim of this investigation is to determine if caloric compensation occurs during 3-day exposure to NNS beverages.


Clinical Trial Description

At the completion of the phone screen, eligible participants will be scheduled to come to the Healthy Eating and Activity Laboratory for the start of their baseline assessment.

The first session will occur the week prior to the test days. At this appointment, informed consent will be obtained, a demographic questionnaire completed, a beverage questionnaire (BEVQ-15) completed, and an appropriate time and preferred mode of contact (text message or e-mail) will be collected. Participant's height and weight will be collected through an electronic scale for weight and a stadiometer for height using standard procedures (Lohman, et al., 1988). Next, participants will be given the SenseWear armband. Participants will be instructed to start wearing the armband upon awakening on Monday morning and to wear the arm band on their upper right arm until going to sleep Monday night (wear time should be at least 10 hours per day). Participants will be instructed to continue wearing the armband, in an identical manner as on Monday, on Tuesday, Wednesday, and Thursday. Participants will be instructed to not alter their physical activity from their normal routine from Monday to Thursday.

Participants will be randomized to one of the three groups, Coke (NS), Diet Coke (NNS), or carbonated water (control) using a random numbers table. For this investigation, Coke and Diet Coke will be used due to Coke and Diet Coke ranked number one and two as the most popular beverages in the U.S. from 2010 to 2018 ("Sweet! America's top 10 brands of soda," 2011; "Top 10 Best Selling Soft Drink Brands in The World," 2016). Next, participants will receive twelve, 12-ounce cans of a beverage that represents their assigned condition. Participants will be instructed to drink their assigned beverages Tuesday through Thursday, and to consume one beverage at 12pm, the second at 3pm, and the third at 6pm. Participants will be instructed that the beverages need to be consumed within +/- 30 minutes of the instructed time. Participants will be instructed that any other beverage consumed on Tuesday through Thursday should be water. Next, instructions will be provided to participants on how to complete the 24-hour dietary recalls and a two-dimensional visual aid will be provided to help participants in estimating portion sizes. Participants will also be given a detailed schedule about their study participation.

Participants will be called on Tuesday, Wednesday, and Thursday to complete 24-hour dietary recalls. Participants will be sent daily reminders regarding their recalls and wearing the armband via text or e-mail (participant preferred mode of contact).

A final appointment will be completed on Friday in the HEAL lab. The armband will be returned and downloaded, the final recall will be completed, and participants will be debriefed about the purpose of the study. Participants will not be responsible for paying for the SenseWear Armband if they lose it or damage it. Once all data are collected, participants will be given a $25 gift card for their participation. If a participant cannot come to the lab on the Friday of their final appointment, then the last recall will be collected via phone and the appointment will be rescheduled in order to collect the armband. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03579043
Study type Interventional
Source The University of Tennessee, Knoxville
Contact
Status Withdrawn
Phase N/A
Start date May 22, 2018
Completion date September 30, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2